Publications Addiction at Any Cost: Philip Morris International Uncovered STOP (Stopping Tobacco Organizations and Products) has published new analyses that show Philip Morris International is addicting new users to its IQOS product because its cigarette business is under threat, not because it solely wants smokers to quit. According to “Addiction at Any Cost: Philip Morris International Uncovered,” PMI also continues marketing its cigarettes to young people and undermining global progress to reduce smoking.
Program Overview Treat TB Clinical Trial Vital Strategies successfully completed implementation of the USAID-funded TREAT TB project, aimed at supporting research to optimize the effectiveness of TB diagnosis and treatment.
Publications Vital Strategies and Partners Organize Training for Criminal Defense Lawyers to Fight Drug Overdose Homicide Laws The Overdose Prevention Program partnered with the National Association of Criminal Defense Lawyers, the Health in Justice Action Lab, and other stakeholders to deliver a first-of-its-kind training on criminal defense against drug overdose homicide cases in Pennsylvania. The curriculum and presentation materials from the training are available, and National Association of Criminal Defense Lawyers has a useful resource page on drug overdose homicide.
Toolkit Medication-Assisted Treatment for Opioid Use Disorder in Jails and Prisons: A Planning and Implementation Toolkit Vital Strategies and the National Council for Behavioral Health have developed a toolkit to help jails and prisons implement and expand access to medications for opioid use disorder, such as methadone and buprenorphine, for incarcerated people struggling with opioid dependence.
Publications Over-the-counter naloxone needed to save lives in the United States The effects of opioid overdose can be dramatically reduced through increased access to the opioid antagonist naloxone. But naloxone is too often unavailable when and where it is most needed, partly due to its continued status as a prescription medication. This commentary argues that the Food and Drug Administration should reclassify naloxone from prescription-only to over-the-counter status.
Technical Guides Accelerating City Progress on Clean Air: Innovation and Action Guide This guide fast-tracks proven approaches and innovations for rapid air quality improvements. It is created for government officials, their partners and other stakeholders developing clean air programs for cities and other urban areas in low and middle income countries.
Publications Scaling Up Effective Treatment of Hypertension This article summarizes lessons learned in the first 2 years of the Resolve to Save Lives (RTSL) hypertension management program, operated in coordination with the World Health Organization (WHO) and other partners.
Publications Fixed-dose combination antihypertensive medications Of the approximately 1.4 billion people with hypertension worldwide, only about one in seven has their blood pressure successfully treated and adequately controlled.
Publications Three Public Health Interventions Could Save 94 Million Lives in 25 Years Preventable noncommunicable diseases, mostly cardiovascular diseases, are responsible for 38 million deaths annually. A few well-documented interventions have the potential to prevent many of these deaths, but a large proportion of the population in need does not have access to these interventions.
Publications Equity First: Conceptualizing a Normative Framework To Assess the Role of Preemption in Public Health This article highlights how preemption—the ability of a higher level of government to limit the regulatory power of a lower level of government—has both created and alleviated health inequities. It proposes the development of an equity-first preemption framework to establish evidence-based criteria for assessing when preemption will enhance or inhibit equity and a research agenda for developing the evidence necessary to inform and operationalize the framework.